Literature DB >> 27812878

Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced Senescence.

Mikhail A Nikiforov1, Donna S Shewach2.   

Abstract

DNA damage response has been characterized as an important mediator of senescence phenotypes induced by activated oncogenes in normal human cells. Depletion of intracellular deoxyribonucleotide pools has been recently recognized as one of the major causes for DNA damage in these cells. Cells undergoing oncogene-induced senescence display decreased expression of several rate-limiting enzymes involved in the biosynthesis of deoxyribonucleotides, including thymidylate synthase (TS) and ribonucleotide reductase (RR). Individual depletion of these enzymes leads to premature senescence. Reciprocally, ectopic expression of TS and RR or addition of deoxyribonucleosides resulted in suppression of senescence phenotypes in normal or tumor cells caused by overexpression of activated HRAS or depletion of C-MYC, respectively. Therefore, in the current chapter, we will describe a methodology for the quantitative measurement of nucleotide pools in senescent cells.

Entities:  

Keywords:  C-MYC; DNA damage; Ribonucleotide reductase (RR); Thymidylate synthase (TS)

Mesh:

Substances:

Year:  2017        PMID: 27812878      PMCID: PMC5579839          DOI: 10.1007/978-1-4939-6670-7_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

Review 1.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

Review 2.  Mechanism of action of hydroxyurea.

Authors:  J W Yarbro
Journal:  Semin Oncol       Date:  1992-06       Impact factor: 4.929

3.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  Nucleotide deficiency promotes genomic instability in early stages of cancer development.

Authors:  Assaf C Bester; Maayan Roniger; Yifat S Oren; Michael M Im; Dan Sarni; Malka Chaoat; Aaron Bensimon; Gideon Zamir; Donna S Shewach; Batsheva Kerem
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

6.  C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.

Authors:  D Zhuang; S Mannava; V Grachtchouk; W-H Tang; S Patil; J A Wawrzyniak; A E Berman; T J Giordano; E V Prochownik; M S Soengas; M A Nikiforov
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

7.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

8.  Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.

Authors:  Chi-Hwa Wu; Jan van Riggelen; Alper Yetil; Alice C Fan; Pavan Bachireddy; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

Review 9.  Many roads lead to oncogene-induced senescence.

Authors:  S Courtois-Cox; S L Jones; K Cichowski
Journal:  Oncogene       Date:  2008-01-14       Impact factor: 9.867

10.  PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.

Authors:  S Mannava; A R Omilian; J A Wawrzyniak; E E Fink; D Zhuang; J C Miecznikowski; J R Marshall; M S Soengas; R C Sears; C D Morrison; M A Nikiforov
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.